Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Bacterial Phylum Chlamydiae01:29

Bacterial Phylum Chlamydiae

422
The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
422
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

916
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
916
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

417
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
417
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

419
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
419
Oogenesis02:07

Oogenesis

69.0K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
69.0K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Discovery of Novel Small-Molecule Inhibitors of PD-1/PD-L1 Interaction via Structural Simplification Strategy.

Molecules (Basel, Switzerland)·2021
Same author

Case Report: Pink Urine Syndrome Following Exposure to Propofol: A Rare, Impressive but Benign Complication.

Frontiers in pharmacology·2021
Same author

TMT-based quantitative proteomic analysis of the effects of Pseudomonas syringae pv. tabaci (Pst) infection on photosynthetic function and the response of the MAPK signaling pathway in tobacco leaves.

Plant physiology and biochemistry : PPB·2021
Same author

Peritumoral Microgel Reservoir for Long-Term Light-Controlled Triple-Synergistic Treatment of Osteosarcoma with Single Ultra-Low Dose.

Small (Weinheim an der Bergstrasse, Germany)·2021
Same author

Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF-κB signalling pathway.

Journal of cellular and molecular medicine·2021
Same author

PSSP-MVIRT: peptide secondary structure prediction based on a multi-view deep learning architecture.

Briefings in bioinformatics·2021

Video Experimental Relacionado

Updated: Jan 15, 2026

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
10:32

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Published on: June 10, 2020

4.5K

Orlistat interfiere con el desarrollo de Chlamydia trachomatis al alterar su ciclo de desarrollo

Jingpin Gao1, Mingxin Jiang1, Jianlin Chen1

  • 1Reproductive Medicine Center, Department of gynecology and obstetrics, The second Xiangya Hospital, Central South University, Changsha, Hunan, China.

Microbial pathogenesis
|January 13, 2026
PubMed
Resumen

Orlistat, un fármaco para perder peso, interrumpe el ciclo de desarrollo de Chlamydia trachomatis, una ITS bacteriana común. Este hallazgo ofrece una nueva estrategia potencial para tratar las infecciones por clamidia donde fallan los antibióticos estándar.

Palabras clave:
Chlamydia trachomatisOrlistatmetabolismo lipídico

Más Videos Relacionados

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

13.3K
Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

13.2K

Videos de Experimentos Relacionados

Last Updated: Jan 15, 2026

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
10:32

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Published on: June 10, 2020

4.5K
A Human Fallopian Tube Model for Investigation of C. trachomatis Infections
09:11

A Human Fallopian Tube Model for Investigation of C. trachomatis Infections

Published on: August 11, 2012

13.3K
Forward Genetic Approaches in Chlamydia trachomatis
09:03

Forward Genetic Approaches in Chlamydia trachomatis

Published on: October 23, 2013

13.2K

Área de la Ciencia:

  • Bacteriología
  • Patogénesis microbiana
  • Descubrimiento de fármacos

Sus antecedentes:

  • Chlamydia trachomatis es una bacteria prevalente de transmisión sexual que causa infecciones urogenitales.
  • Las infecciones pueden provocar inflamación crónica y fibrosis debido a la progresión asintomática.
  • Los tratamientos actuales como la azitromicina y la doxiciclina enfrentan fallos terapéuticos documentados.

Objetivo del estudio:

  • Investigar el potencial de orlistat para interrumpir el ciclo de desarrollo de Chlamydia trachomatis.
  • Evaluar la eficacia de orlistat contra la infección por clamidia in vitro e in vivo.

Principales métodos:

  • Se utilizaron modelos in vitro e in vivo para evaluar el efecto de orlistat en Chlamydia trachomatis.
  • Se empleó análisis transcriptómico para comprender el impacto en la expresión génica durante la infección.

Principales resultados:

  • Orlistat demostró la inhibición de las etapas tempranas de la infección por clamidia.
  • El fármaco interfirió con la replicación del cuerpo reticulado y la diferenciación en cuerpos elementales.
  • Los datos transcriptómicos mostraron una regulación decreciente de genes cruciales para el desarrollo de clamidia de etapa media a tardía.

Conclusiones:

  • Orlistat interrumpe el ciclo de desarrollo de Chlamydia trachomatis.
  • Los hallazgos sugieren orlistat como un agente terapéutico potencial contra las infecciones por clamidia, particularmente aquellas resistentes a los antibióticos convencionales.
  • Se necesita más investigación para dilucidar completamente los mecanismos de acción de orlistat contra Chlamydia trachomatis.